Published in Cardiovascular Business Week, June 28th, 2005
"Inflammation plays an important role in the initiation and progression of atherosclerosis and the development of atherosclerotic events. Understanding the molecular basis of inflammation has led to the identification of markers that may also serve as new targets of therapy in the management of atherothrombotic disease," researchers in the United States report.
C. Ballantyne and colleagues of the Baylor College of Medicine continued, "Inflammatory markers, Such as C-reactive protein (CRP), have been shown to predict future cardiovascular events in individuals with and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.